Trader consensus on Polymarket reflects an 82.5% implied probability against a new COVID variant of concern before 2027, anchored by WHO and ECDC classifications showing no VOCs since Omicron in 2022—despite vigilant wastewater surveillance and genomic sequencing. The BA.3.2 "Cicada" variant, a highly mutated Omicron sublineage emerging late 2025 and peaking in U.S./European circulation by April 2026, remains a variant under monitoring due to lacking evidence of heightened transmissibility, severity, or vaccine escape driving hospitalizations. Dominant strains like XFG.1.1 now prevail amid broad population immunity from boosters and infections, with stable case trends reinforcing low risk; only a dramatic immune-evasion surge could tip the balance.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · Diperbarui$238,689 Vol.
$238,689 Vol.
$238,689 Vol.
$238,689 Vol.
The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Pasar Dibuka: Dec 1, 2025, 4:49 PM ET
Resolver
0x65070BE91...The CDC's variant classification scheme can be found here: https://stacks.cdc.gov/view/cdc/107682.
The resolution source for this market will be official information from the CDC.
Resolver
0x65070BE91...Trader consensus on Polymarket reflects an 82.5% implied probability against a new COVID variant of concern before 2027, anchored by WHO and ECDC classifications showing no VOCs since Omicron in 2022—despite vigilant wastewater surveillance and genomic sequencing. The BA.3.2 "Cicada" variant, a highly mutated Omicron sublineage emerging late 2025 and peaking in U.S./European circulation by April 2026, remains a variant under monitoring due to lacking evidence of heightened transmissibility, severity, or vaccine escape driving hospitalizations. Dominant strains like XFG.1.1 now prevail amid broad population immunity from boosters and infections, with stable case trends reinforcing low risk; only a dramatic immune-evasion surge could tip the balance.
Ringkasan eksperimental yang dihasilkan AI dengan referensi data Polymarket. Ini bukan saran trading dan tidak berperan dalam bagaimana pasar ini diselesaikan. · Diperbarui
Hati-hati dengan link eksternal.
Hati-hati dengan link eksternal.
Pertanyaan yang Sering Diajukan